Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2004-05-21
2008-05-27
Foley, Shanon (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S190100, C536S023700, C435S069100, C435S252300, C530S300000, C530S350000
Reexamination Certificate
active
07378101
ABSTRACT:
The present invention relates to novel bacterial isolates identified by their 16S rRNA DNA, that cause periodontal disease in companion animals, polynucleotide sequences contained therein, polypeptides encoded by such polynucleotide sequences and vaccines comprising such bacteria, polynucleotides, or polypeptides. Also provided are methods for treating and preventing periodontal disease and kits for detecting and treating periodontal disease kits for detecting and preventing periodontal disease. In addition, methods for assessing the efficacy of a vaccine against periodontal diseases in an animal are provided.
REFERENCES:
patent: 4661350 (1987-04-01), Tsurumizu et al.
patent: 5536497 (1996-07-01), Evans et al.
patent: 6160087 (2000-12-01), Ogawa
patent: 61-140527 (1986-06-01), None
patent: WO 95/09181 (1995-04-01), None
patent: WO 95/10612 (1995-04-01), None
patent: WO 01/83530 (2001-11-01), None
J Clin Microbiol. Mar. 2002; 40(3): 1044-1047.
Kesavalu L, Infect Immun. Apr. 1992;60(4):1455-64.
Dickinson D.P. et al., “Molecular Cloning and Sequencing of the Gene Encoding the Fimbrial Subunit Protein ofBacteroides gingivalis”, Journal of Bacteriology170(4):1658-1665 (1988).
Evans R.T. et al., “Immunization withPorphyromonas(Bacteroides)gingivalisFimbriae Protects against Periodontal Destruction”,Infection and Immunity60(7):2926-2935 (1992).
Collins M.D. et al., “Phylogenetic Analysis of Members of the GenusPorphyromonasand Description ofPorphyromonas cangingivalissp. nov. andPorphyromonas cansulcisp. nov.”,International Journal of Systematic Bacteriology44(4):674-679 (1994).
Harvey C.E. et al., “Subgingival Bacteria-Comparison of Culture Results in Dogs and Cats With Gingivitis”,J. Vet. Dent. 12(4):147-150 (1995).
Allaker R.P. et al., “Prevalence ofPorphyromonasandPrevotellaspecies in the dental plaque of dogs”The Veterinary Record 140(6):147-148 (1997).
Norris J.M. et al., “Associations amongst three felinePorphyromonasspecies from the gingival margin of cats during periodontal health and disease”,Veterinary Microbiology 65:195-207 (1999).
Sharma A. et al., “Oral Imunization with RecombinantStreptococcus gordoniiExpressingPorphyromonas gingivalisFimA Domains”,Infection and Immunity 69(5):2928-2934 (2001).
Ross B.C. et al., “Identification of vaccine candidate antigens from a genomic analysis ofPorphyromonas gingivalis”, Vaccine 19:4135-4142 (2001).
Geneco C. A. et al., “Animal models forPorphyromonas gingivalis-mediated periodontal disease”,Trends In Microbiology 6(11): 444-449 (1998).
Grecca F. S. et al., “Radiographic Evaluation of Periradicular Repair after Endodontic Treatment of Dog's Teeth with Induced Periradicular Periodontitis”,Journal of Endodontics 27(10): 610-612 (2001).
Dreier Kimberly Jean
Hardham John Morgan
Haworth John David
King Kendall Wayne
Krishnan Rajendra
Baskar Padma
Foley Shanon
Pfizer Inc.
Pfizer Products Inc.
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Vaccine for periodontal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine for periodontal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine for periodontal disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3987230